In a large U.S. cohort study, both forms of administration were equally safe — and necessity of follow-up was lower among women treated via telemedicine.
The advent of medication abortion enables delivery of this care via telemedicine, an option that is especially important in states where access to abortion providers is limited to a few urban areas. To evaluate the outcomes of in-clinic versus telemedicine-delivered medication abortion, investigators reviewed medical records at 26 Planned Parenthood centers in Alaska, Idaho, Nevada, and Washington. All participants were evaluated and received counseling at the centers.
Of 5952 women, 738 (mean gestational age, 50.4 days) had telemedicine encounters with providers and 5214 (mean, 48.9 days) had in-clinic encounters. Follow-up was ascertained in 60% of the telemedicine group and 77% of the clinic group. Continuing pregnancy was less common amo…
Reviewing Author
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)